Features of complementary and alternative medicine use by patients with coronary artery disease in Beijing: a cross-sectional study

BMC Complementary and Alternative Medicine

Hong-Xu Liu¹  Jie Wang⁴  Xing-Jiang Xiong⁴  Ze Zhang²  Xue Yan³  Fu-Yong Chu¹ 

[1] Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China;Department of Gerontology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China;Department of Psychology and Sleep Medicine, Guang An Men Hospital, China Academy of Chinese Medical Sciences, Beijing, China;Department of Cardiology, Guang An Men Hospital, China Academy of Chinese Medical Sciences, Beijing, China

关键词: Patent herbal medicine;    Cross sectional study;    CAD;    CAM use;   

Others  :  1220869
DOI  :  10.1186/1472-6882-13-287

 received in 2013-06-17, accepted in 2013-10-23,  发布年份 2013

【 摘 要 】

Background

Complementary and alternative medicine (CAM) is commonly used in China for the management of coronary artery disease (CAD). However, few studies have been conducted to investigate the prevalence, perceived effectiveness, types, and reasons of CAM use in patients diagnosed with CAD.

Methods

A cross-sectional study design was adopted. Questionnaires were distributed at the outpatient cardiac clinics of four tertiary-level teaching general hospitals in Beijing. Quantitative data were analyzed using Student’s t-test. Categorical data were analyzed using chi-square test. Logistic regression was employed to explore factors associated with the use of CAM as well as CAM use features in Chinese medicine (CM) hospitals when significant differences were found upon comparisons.

Results

From May to July, 2009, a total of 600 questionnaires were distributed, and 546 patients with a diagnosis of CAD responded with valid values and were included in the present study. CAM was used by 69.1% of the patients with CAD; the majority (75.9%) of these CAM users believes that CAM is effective. “Few side effects” (49.6%) was the main reason of CAM use; whereas “doubt of effect” (61.5%) was the main reason for non-use. Patent herbal medicine (90.7%) was the most commonly used CAM type. Compared with non-CAM users, CAM users tended to be older (p < 0.01), have a longer disease duration (p = 0.02) and better current health status. In addition, CAM users had significant lower odds for emergency admission and hospitalization within the past one year. Patients with CAD from CM and WM hospitals differ in CAM use frequency, types, perceived effectiveness, as well as reasons for CAM use or non-CAM use.

Conclusion

The present study suggested a group of significant factors which could influence the use of CAM in patients with CAD. CAM use patterns differ in patients from CM and WM hospitals.

【 授权许可】

   
2013 Chu et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Libby P, Theroux P: Pathophysiology of coronary artery disease. Circulation 2005, 111:3481-3488.
• [2]McGill HC Jr, McMahan CA, Gidding SS: Preventing heart disease in the 21st century: implications of the pathobiological determinants of atherosclerosis in youth (PDAY) study. Circulation 2008, 117(9):1216-1227.
• [3]Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA, AHA/ACC; National Heart, Lung, and Blood Institute: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006, 113(19):2363-2372.
• [4]Zhang XH, Lu ZL, Liu L: Coronary heart disease in China. Heart 2008, 94(9):1126-1131.
• [5]Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, Zeng Z, Wu Y: Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation 2001, 103:462-468.
• [6]Wang W, Lau Y, Chow A, Thompson DR, He HG: Health-related quality of life and social support among Chinese patients with coronary heart disease in mainland China. Eur J Cardiovasc Nurs 2013. Epub ahead of print
• [7]Intarakamhang P, Intarakamhang U: Effects of the comprehensive cardiac rehabilitation program on psychological factors and quality of life among coronary heart disease patients. Glob J Health Sci 2012, 5(2):145-52.
• [8]Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M: Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006, 27:1610-1619.
• [9]Jaworski R, Jankowska EA, Ponikowski P, Banasiak W: Costs of management of patients with coronary artery disease in Poland: the multicenter RECENT study. Pol Arch Med Wewn 2012, 122(12):599-607.
• [10]Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998, 280:1569-1575.
• [11]Thomas KJ, Nicholl JP, Coleman P: Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 2001, 9:2-11.
• [12]Boon H: Regulation of complementary/alternative medicine: a Canadian perspective. Complement Ther Med 2002, 10:14-19.
• [13]Foltz V, St Pierre Y, Rozenberg S, Rossignol M, Bourgeois P, Joseph L, Adam V, Penrod JR, Clarke AE, Fautrel B: Use of complementary and alternative therapies by patients with self-reported chronic back pain: a nationwide survey in Canada. Joint Bone Spine 2005, 72:571-577.
• [14]Hilsden RJ, Verhoef MJ, Best A, Pocobelli G: Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 2003, 98:1563-1568.
• [15]MacLennan AH, Wilson DH, Taylor AW: Prevalence and cost of alternative medicine in Australia. Lancet 1996, 347:569-573.
• [16]Shmueli A, Shuval J: Use of complementary and alternative medicine in Israel: 2000 vs. 1993. Isr Med Assoc J 2004, 6:3-8.
• [17]Sorsdahl K, Stein DJ, Grimsrud A, Seedat S, Flisher AJ, Williams DR, Myer L: Traditional healers in the treatment of common mental disorders in South Africa. J Nerv Ment Dis 2009, 197:434-441.
• [18]Decker C, Huddleston J, Kosiborod M, Buchanan DM, Stoner C, Jones A, Banerjee S, Spertus JA: Self-reported use of complementary and alternative medicine in patients with previous acute coronary syndrome. Am J Cardiol 2007, 99(7):930-3.
• [19]Prasad K, Sharma V, Lackore K, Jenkins SM, Prasad A, Sood A: Use of complementary therapies in cardiovascular disease. Am J Cardiol 2013, 111(3):339-45.
• [20]Grant SJ, Bin YS, Kiat H, Chang DH: The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health 2012, 12:299.
• [21]What is CAM: National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/health/whatiscam webcite (accessed 3/7/2013)
• [22]Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O’Rourke RA, Pasternak RC, Williams SV, American College of Cardiology; American Heart Association Task Force on practice guidelines: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article. J Am Coll Cardiol 2003, 41:159-168.
• [23]Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction. J Am Coll Cardiol 2007, 50:e1-e157.
• [24]Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, American College of Cardiology; American Heart Association; Canadian Cardiovascular Society: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. J Am Coll Cardiol 2004, 44:671-719.
• [25]Liu TX, Kong SP, Liao ZY, Lu SK: Assessment study on physical function and the quality of life for CAD patients with Seattle Angina Questionnaire. Chin J Behavi Med Sci 1997, 6:127-129.
• [26]Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA: Dangerous combinations: ingestible CAM supplement use during chemotherapy in patients with ovarian cancer. J Altern Complement Med 2013, 19(8):714-20.
• [27]Vickers AJ, Cronin AM, Maschino AC, Lewith G, MacPherson H, Foster NE, Sherman KJ, Witt CM, Linde K, Acupuncture Trialists’ Collaboration: Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med 2012, 172(19):1444-53.